Amneal Pharmaceuticals, Inc Class A Common Stock

Amneal Pharmaceuticals, Inc Class A Common Stock

Quarterly Financials

Values in thousands2026-09-302026-06-302026-03-312025-12-31
Revenue
$862,684
$796,197
$722,519
$814,319
Gross Profit
334,118
334,508
320,113
297,190
EBITDA
127,229
193,780
186,061
160,699
EBIT
73,970
145,980
142,870
111,472
Net Income
-7,456
57,662
62,256
35,076
Net Change In Cash
862,684
796,197
722,519
814,319
Free Cash Flow
60,698
-64,854
-42,585
87,146
Cash
157,399
127,637
197,656
310,871
Basic Shares
335,733
328,102
328,933
324,805

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$3,018,760
$2,793,957
$2,393,607
$2,212,304
Gross Profit
1,136,092
1,020,438
863,869
791,461
EBITDA
603,872
439,773
500,782
440,208
EBIT
380,300
203,582
271,382
200,033
Net Income
72,057
-116,886
-83,993
-129,985
Net Change In Cash
3,018,760
2,793,957
2,393,607
2,212,304
Cost of Revenue
-215,829
Free Cash Flow
269,929
220,109
276,388
-25,495
Cash
310,871
110,552
91,542
25,976
Basic Shares
324,805
308,978
176,136
150,944

Earnings Calls

QuarterEPS
2026-09-30
$0.24
2026-06-30
$0.27
2026-03-31
$0.27
2025-12-31
$0.21